Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
MedActive Oral Relief Lozenges are an over-the-counter (OTC) oral care product developed and manufactured by Integrate Oral Care. These lozenges are formulated as a saliva stimulant combination intended to provide temporary relief from minor oral discomfort, sore throat, and symptoms of dry mouth (xerostomia). The key active components include **Ultramulsion**, a proprietary dimethicone-based emulsion designed to coat and protect irritated oral tissues, and **Spilanthes extract** (derived from the *Spilanthes acmella* plant). Spilanthes extract contains spilanthol, which acts as a sialogogue to stimulate natural saliva production. The product is sugar-free, gluten-free, and available in various flavors, including raspberry and orange creme. It is marketed as an OTC product that complies with applicable regulations for oral care and saliva stimulants.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on MedActive Oral Relief Lozenges.